Squarepoint
BSTC

Squarepoint’s BioSpecifics Technologies Corp. BSTC Stock Holding History

Squarepoint’s Portfolio BSTC Stock Details BSTC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-4,328
Closed -$265K – 3002
2020
Q2 		$265K Sell
4,328
-1,891
-30% -$109K ﹤0.01% 1684
2020
Q1 		$352K Sell
6,219
-20,223
-76% -$1.15M 0.01% 1219
2019
Q4 		$1.51M Buy
26,442
+8,220
+45% +$436K 0.01% 1070
2019
Q3 		$975K Buy
18,222
+1,089
+6% +$63.4K 0.01% 1255
2019
Q2 		$1.02M Buy
17,133
+9,419
+122% +$593K 0.01% 1252
2019
Q1 		$481K Sell
7,714
-236
-3% -$15.6K 0.01% 1504
2018
Q4 		$482K Buy
7,950
+192
+2% +$11.5K 0.01% 1269
2018
Q3 		$454K Buy
+7,758
New +$396K 0.01% 1347

Other funds holding BSTC

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RHJA
Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return

Squarepoint's BSTC Position: Q3 2020 in Review

Squarepoint sold out of BioSpecifics Technologies Corp. (BSTC) in Q3 2020, closing a stake of 4,328 shares — an estimated $265K sold.

Squarepoint first reported a position in BSTC in Q3 2018 and held it in 8 quarters. The position peaked at $1.51M in Q4 2019. 113 funds tracked by Wall St. Rank hold BSTC as of Q3 2020.

  • Squarepoint reported no remaining BioSpecifics Technologies Corp. position as of Q3 2020 after selling out during the quarter.
  • Squarepoint sold 4,328 BioSpecifics Technologies Corp. shares in Q3 2020, an estimated $265K.
  • Squarepoint first reported a position in BioSpecifics Technologies Corp. in Q3 2018 and held it in 8 quarters.
  • Squarepoint's BioSpecifics Technologies Corp. position peaked at $1.51M in Q4 2019.
  • 113 funds tracked by Wall St. Rank held BioSpecifics Technologies Corp. as of Q3 2020.

Based on Squarepoint's 13F filing for Q3 2020, filed 16 Nov 2020.